EARLY ALZHEIMER'S DISEASE
Clinical trials for EARLY ALZHEIMER'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new EARLY ALZHEIMER'S DISEASE trials appear
Sign up with your email to follow new studies for EARLY ALZHEIMER'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could ALZ-801 slow Alzheimer's in those with two copies of the APOE4 gene?
Disease control CompletedThis study tested an experimental drug called ALZ-801 in 325 people with early Alzheimer's disease who carry two copies of the APOE4 gene (APOE4/4), which raises risk. Participants received either the drug or a placebo for about a year. Researchers measured changes in memory, thi…
Matched conditions: EARLY ALZHEIMER'S DISEASE
Phase: PHASE3 • Sponsor: Alzheon Inc. • Aim: Disease control
Last updated May 26, 2026 06:14 UTC
-
New pill may slow Alzheimer's in High-Risk gene carriers
Disease control CompletedThis study tested an oral drug called ALZ-801 in 84 people with early Alzheimer's who carry the APOE4 gene variant, which increases risk. The goal was to see if the drug affects brain-related markers and is safe. Participants took the drug for 65 weeks, and researchers measured c…
Matched conditions: EARLY ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Alzheon Inc. • Aim: Disease control
Last updated May 26, 2026 05:49 UTC
-
Could a diabetes pill slow Alzheimer's? major trial results are in
Disease control CompletedThis large Phase 3 study tested whether a daily pill called semaglutide (a diabetes drug) can slow cognitive decline in people with early Alzheimer's disease. About 1,840 participants received either semaglutide or a placebo for up to 3 years and 4 months. The study measured chan…
Matched conditions: EARLY ALZHEIMER'S DISEASE
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 26, 2026 05:48 UTC
-
Could a diabetes pill be the key to slowing Alzheimer's?
Disease control CompletedThis study tested whether oral semaglutide, a drug already used for diabetes, can slow the progression of early Alzheimer's disease. About 1,840 people with mild cognitive impairment or mild dementia took either the drug or a placebo for up to 3 years and 4 months. Researchers tr…
Matched conditions: EARLY ALZHEIMER'S DISEASE
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 22, 2026 13:51 UTC